Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preclinical and clinical evidence for stem cell therapies as treatment for diabetic wounds.

Drug discovery today - 1 Jun 2015

Heublein Hannes, Bader Augustinus, Giri Shibashish

Abstract excerpt

Diabetic wounds remain a global unsolved problem and the cost of diabetes-related amputations and diabetic wound treatment is approximately US$3 billion and US$9 billion per year, respectively. Diabetic foot ulcers (DFUs) occur in 15% of all patients with diabetes and precede 84% of all diabetes-related lower leg amputations. Currently, there is no satisfying treatment for these hard-to-heal-wounds. However, as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Differentiation
Share to Cell Lineage
Share to Cell Proliferation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Signal Transduction

Share to Stem Cell Transplantation

Share to Stem Cells

Share to Treatment Outcome

Share to Wound Healing

Source

Identifiers

PMID: 25603421
DOI: 10.1016/j.drudis.2015.01.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preclinical and clinical evidence for stem cell therapies as treatment for diabetic wounds.PMID 25603421Read ↗

Mesenchymal Stem Cells Improve Healing of Diabetic Foot Ulcer.Semantic proximity Read ↗

Differentiation of diabetic foot ulcer-derived induced pluripotent stem cells reveals distinct cellular and tissue phenotypes.Semantic proximity Read ↗

Insights into the role of adipose-derived stem cells: Wound healing and clinical regenerative potential.Semantic proximity Read ↗

iPSC-derived exosomes promote diabetic wound healing by attenuating inflammatory responsesSemantic proximity Read ↗

Diabetes treatment: A rapid review of the current and future scope of stem cell researchSemantic proximity Read ↗

Emerging technologies in regenerative medicine: The future of wound care and therapySemantic proximity Read ↗

Therapeutic potential of mesenchymal stem cells for diabetes.Semantic proximity Read ↗

Cellular Senescence as the Pathogenic Hub of Diabetes-Related Wound ChronicitySemantic proximity Read ↗

Human periodontal ligament stem cells (hPDLSCs) spontaneously differentiated into myofibroblast to repairer diabetic woundsSemantic proximity Read ↗

Healing mechanism of diabetic foot ulcers using single-cell RNA-sequencingSemantic proximity Read ↗

Genetic and epigenetic events in diabetic wound healing.Semantic proximity Read ↗

Generation of Induced Pluripotent Stem Cells from Diabetic Foot Ulcer Fibroblasts Using a Nonintegrative Sendai VirusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.